Logotype for Singapore Exchange Limited

Singapore Exchange (S68) H2 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Singapore Exchange Limited

H2 2024 earnings summary

26 Aug, 2026

Executive summary

  • FY2024 revenue increased 3.1% to S$1,231.7 million, with adjusted net profit up 4.5% to S$525.9 million, driven by strong growth in currencies and commodities, while equities segments declined.

  • The multi-asset strategy diversified revenue, with FICC, equities, and derivatives each contributing about a quarter of total revenue, and platforms/other businesses making up 20%.

  • Board proposed a final quarterly dividend of 9.0 cents per share, up from 8.5 cents, for a 5.9% annualised increase.

  • Adjusted operating profit margin was 50.7%, and adjusted NPAT margin was 42.1%.

  • The group remains focused on expanding its FX and commodities franchises, enhancing product offerings, and deepening regional and global connectivity.

Financial highlights

  • Derivatives revenue grew 2% to comprise 45% of total revenue, with 8% volume growth; currency futures DAV up 35%, commodities DAV up 50%, and OTC FX ADV up 47% to US$111.1 billion.

  • Cash equity market activity remained subdued, with SDAV down 4% year-on-year and cash market revenue down 2%.

  • Platform and Others revenue increased 5.6% to S$240.2 million, with market data and connectivity both up 9.0%.

  • Adjusted expenses rose 2.5% to S$604 million, mainly from higher staff and technology costs.

  • Net fair value gain of over S$100 million from revaluation of investment in Trading Technologies.

Outlook and guidance

  • Group targets 6%-8% CAGR in revenue (excluding treasury income) over the medium term, led by low- to mid-teens % growth in OTC FX and exchange-traded derivatives.

  • Expense growth expected at 2%-4% in FY2025, with medium-term organic expense growth in the low- to mid-single-digit % range.

  • CapEx guided at S$70-75 million for FY2025, focused on modernization and infrastructure upgrades.

  • Scientific Beta underperformance may lead to strategic repositioning and potential goodwill impairment.

  • Dividend per share increased to S$0.345 for FY2024, with a stated aim for mid-single-digit % growth in the medium term.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more